ARS Pharmaceuticals Names Donn Casale President to Drive Growth in Chronic Urticaria & Nasal Spray Innovation
ARS Pharmaceuticals names Donn Casale president, boosting growth in chronic urticaria and epinephrine nasal spray while leveraging its ImmunoTAC platform for patient‑centric breakthroughs.
3 minutes to read